Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Study offers insights into treatment of FIP
cat
FIP is usually found in young cats that are less than three years old.
Researchers successfully treat cats in late stage of the disease

US vets have successfully managed to treat laboratory cats suffering from the advanced stage of feline infectious peritonitis (FIP), a previously 100 per cent fatal disease.

In a study published in the journal PLOS Pathogens, researchers from Kansas State University describe their success with an antiviral treatment that stops the virus replicating.

When treatment was started at a late stage of disease, the researchers found that the cats returned to normal health within 20 days or less.

FIP is usually found in young cats that are less than three years old. Caused by coronavirus infection, most cats do not develop any symptoms at all. Yet, a small percentage of cats do go on to develop FIP.

FIP occurs in two forms: wet or dry. The wet form is more common and can be characterised by an accumulation of fluids in the abdominal area or chest cavity.

Symptoms may include fever, jaundice, and weight loss. Once set in it can progress rapidly, resulting in death or euthanasia.

Because of the rapid progression of the disease, it has not been known whether antiviral drug treatment can be effective at reversing disease progression in an infected cat.

"This is the first time we showed experimental evidence of successful treatment of laboratory cats at an advanced clinical stage of FIP," said Yunjeong Kim, an associate professor in the college’s diagnostic medicine pathobiology department.

"The knowledge gained from this study is a step forward to understanding the pathogenesis of FIP and other coronavirus infections important in humans and animals.”

Dr Kim says that the next step will be to find out how effective the antiviral treatment is for cats with naturally acquired FIP.

Become a member or log in to add this story to your CPD history

Building Great Workplaces webinars return

News Story 1
 BVA has announced a new series of its Building Great Workplaces lunchtime webinars.

Launching from 16 July, the sessions will explore patient safety, motivation, client communication and more.

Its first webinar, exploring neurodiversity in the workplace, will take place at 1pm on Thursday, 16 July. It will feature guest speakers from The Vet Project, a group which supports neurodiversity in veterinary environments.

The following three webinars take place in September, October and November.

Booking is open on the BVA website 

Click here for more...
News Shorts
New form for online veterinary medicines retailers

The Veterinary Medicines Directorate (VMD) has produced a new online form for retailers wishing to sell veterinary medicines on the internet.

The form replace the previous Word version and is part of the VMD's ongoing commitment to digitise its processes. Anyone retailing prescription medicines online, including POM-V, POM-VPS and NFA-VPS categories, is lawfully required to register with the VMD before trading.

The change only applies to new applicants. Retailers already listed on the VMD's Register of Online Retailers or registered under the Accredited Internet Retailer Scheme (AIRS) do not need to do anything.